ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

140
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
21 Mar 2019 00:00

Asia HY Trade Recommendations - March 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for March includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
64 Views
Share
01 Mar 2019 00:00

Asia HY Monthly - Oil & Gas Overview - Lucror Analytics

In this month’s “In-Focus” section, we look at key developments in the global oil & gas markets in 2018 and consider the 2019 outlook. We...

Logo
67 Views
Share
22 Feb 2019 00:00

Asia HY Trade Recommendations - February 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for February includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
55 Views
Share
18 Feb 2019 00:00

Glenmark - Earnings Flash - Q3 FY 2018-19 Results - Lucror Analytics

Glenmark’s Q3/18-19 results very much surprised on the upside, with strong revenue and earnings growth after a few weak quarters. This was thanks...

Logo
62 Views
Share
04 Feb 2019 00:00

Asia HY Monthly - Agency Ratings For Asian Issuers - Lucror Analytics

In this month’s “In-Focus” section, we look at agency ratings for Asian issuers. The Asia Monthly focuses on providing updates on recent events,...

Logo
78 Views
Share
x